Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, Maharashtra, India.
Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai, Maharashtra, India.
Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):630-5. doi: 10.1016/j.ijrobp.2013.11.214.
The present study investigates relationship between dose-volume parameters and severe bowel toxicity after postoperative radiation treatment (PORT) for cervical cancer.
From June 2010 to December 2012, a total of 71 patients undergoing PORT were included. Small bowel (SB) and large bowel (LB) loops were contoured 2 cm above the target volume. The volume of SB and LB that received 15 Gy, 30 Gy, and 40 Gy was calculated (V15 SB, V15 LB, V30 SB, V30 LB, V40 SB, V 40 LB). On follow-up, bowel toxicity was scored using Common Terminology Criteria for Adverse Events (CTCAE), version 3.0. A reciever operating characteristic (ROC) curve identified volume thresholds that predicted for grade 3 or higher toxicity with highest specificity. All data was dichotomized across these identified cut-off values. Univariate and multivariate analysis was performed using SPSS, version 15.
The median patient age was 47 years (range, 35-65 years). Of the 71 patients, 46 received image-guided intensity modulated radiation therapy, and 25 received conformal radiation (50 Gy in 25 fractions for 5 weeks). Overall, 63 of 71 patients received concurrent chemotherapy. On a median follow-up of 18 months (range, 8-29 months), grade 2 or higher bowel toxicity was seen in 22 of 71 patients (30.9%) and grade 3 or higher bowel toxicity was seen in 9 patients (12.6%). On univariate analysis, V15 SB <275 cc (P=.01), V30 SB <190 cc (P=.02), V40 SB <150 cc (P=.01), and V15 LB <250 cc (P=.03), and V40 LB <90 cc (P=.04) predicted for absence of grade 3 or higher toxicity. No other patient- or treatment-related factors were statistically significant. On multivariate analysis, only V15 SB (P=.002) and V15 LB (P=.03) were statistically significant.
V 15 Gy SB and LB are independent predictors of late grade 3 or higher toxicity. Restricting V15 SB and V15 LB to <275 cc and <250 cc can reduce grade 3 or higher toxicity to less than 5%.
本研究旨在探讨宫颈癌术后放疗(PORT)后剂量-体积参数与严重肠道毒性之间的关系。
自 2010 年 6 月至 2012 年 12 月,共纳入 71 例行 PORT 的患者。将小肠(SB)和大肠(LB)环勾画在靶体积上方 2 cm 处。计算 SB 和 LB 接受 15 Gy、30 Gy 和 40 Gy 的体积(V15SB、V15LB、V30SB、V30LB、V40SB、V40LB)。随访时,采用常见不良事件术语标准(CTCAE),版本 3.0 对肠道毒性进行评分。受试者工作特征(ROC)曲线确定了预测 3 级或更高级别毒性的最佳特异性的体积阈值。所有数据均根据这些确定的截止值进行二分法处理。使用 SPSS 版本 15 进行单变量和多变量分析。
中位患者年龄为 47 岁(范围 35-65 岁)。71 例患者中,46 例接受图像引导调强放疗,25 例接受适形放疗(50 Gy 分 25 次,每周 5 次)。总体而言,71 例患者中有 63 例接受了同期化疗。中位随访时间为 18 个月(范围 8-29 个月),71 例患者中有 22 例(30.9%)发生 2 级或更高级别的肠道毒性,9 例(12.6%)发生 3 级或更高级别的肠道毒性。单变量分析显示,V15SB<275cc(P=.01)、V30SB<190cc(P=.02)、V40SB<150cc(P=.01)和 V15LB<250cc(P=.03),以及 V40LB<90cc(P=.04)预测 3 级或更高毒性的不存在。没有其他与患者或治疗相关的因素具有统计学意义。多变量分析显示,只有 V15SB(P=.002)和 V15LB(P=.03)具有统计学意义。
V15GySB 和 LB 是晚期 3 级或更高毒性的独立预测因子。将 V15SB 和 V15LB 限制在<275cc 和<250cc 可以将 3 级或更高毒性降低到<5%。